Xcellerant Ventures invests in technologies that power the future of healthtech by providing solutions that improve quality, access, and delivery of care at lowered costs.
We lead with a people first philosophy. When we put our knowledge, power, and experience into people, we empower these forward-thinking companies to change the world for the better.
Invest today in tomorrow’s transformation.
Revolutionizing chronic disease management through groundbreaking approaches to targeted genetic sequencing and comprehensive genetic data collection.
We deliver solutions that eliminate friction points in the patient encounter as we create end-to-end efficiencies in the clinic.
Peace of mind through innovation – The ReFlow™ Ventricular System.
Revolutionizing chronic disease management through groundbreaking approaches to targeted genetic sequencing and comprehensive genetic data collection.
Delivering solutions that eliminate friction points in the patient encounter as we create end-to-end efficiencies in the clinic.
Peace of mind through innovation – The ReFlow™ and ReFlow™ Mini Ventricular Systems for hydrocephalus patients.
Multiplying the value patients get from their prescription eye medications.
Bringing next-generation payment technology to the medical field.
Leveraging AI-driven insights to optimize patient outcomes–with the convenience of a mobile app.
Copyright © 2022 Xcellerant Ventures | Privacy Policy
MD, JD, MBA, FACEP
John received his BA from Drake and his MD from the Rosalind Franklin. He completed his Emergency Medicine Residency at Christ Hospital where he was Chief Resident. John received his MBA in 1995, and his JD in 2005, both from ASU. In 2015, he completed his Six Sigma Black Belt from the Fulton School of Engineering. In 2019 he completed a certificate program in Artificial Intelligence at MIT. He founded NextCare Inc. in 1993 as well as numerous other health and non-health care businesses. He is the business manager and one of the founding partners of Empower Emergency Physicians and continues to practice emergency medicine. In 2010, John founded MeMD. MeMD is used by more than 500 providers in 50 states to virtually treat patients on-demand. MeMD sold to Walmart in June, 2021. In 2015, John founded Tribal EM, an emergency medicine staffing and management company dedicated to improving the delivery of healthcare for Indigenous People. He has authored 12 books on business, personal growth, leadership, and urgent care medicine and management.
Ph.D.
Chris has over 25 years of experience in advancing cutting-edge biomedical information technology in the Healthcare & Life Sciences industry. Chris most recently operated Yoo & Co Accelerators, the premier business accelerator in Arizona for healthcare & life sciences startups. Chris is an active angel investor and, as a serial entrepreneur, has created value in new companies that accelerate the adoption of smarter, technology-based systems such as cognitive computing, big data analytics, and systems engineering. Some of his prior ventures include Systems Oncology, an oncology biotechnology company, Systems Imagination, a pioneer in advanced cognitive computing for drug discovery, and MedTrust Online, the world’s first and largest online community of cancer doctors. He has also developed some of the earliest solutions and strategies in personalized medicine for companies such as Cisco, Applied Biosystems, Oracle, and IBM. Chris participates on the boards of several companies where he enjoys working arm-in-arm with the next generation of entrepreneurs and innovators. Chris is faculty at Arizona State University and Grand Canyon University teaching courses in molecular diagnostics and in entrepreneurship. He completed a postdoctoral fellowship at UC Berkeley, his PhD in Cell and Molecular Biology from Yale University School of Medicine, and a B.S. in History and Biology from the University of Pennsylvania.
LLM, JD
Doug has focused on innovation throughout his career as a lawyer, professor, and then dean of the Sandra Day O’Connor College of Law. His legal career focused on tech licensing and helping start-up companies establish themselves and protect their intellectual property. As a professor and dean, his teaching and scholarship focused on using the law to facilitate innovation. More important, he drove innovation at the law school at every level—launching new programs, ventures, and start-ups. As the founder of the ASU Innovation Advancement Program, he and his programs have helped dozens of companies launch and succeed. He was a member of the Global e-Commerce Practice Group at the law firm of Baker & McKenzie representing, almost exclusively, start-up technology companies. He has taught at the Northwestern University Kellogg School of Business as well as the University of Chicago and, of course, Arizona State University College of Law, as well as at the business school there. Recently awarded Phoenix Business Journal “Most Admired Leader” honor and nominated for the AzTech Council “Transformational Leadership Award” in 2020, Doug looks forward to bringing his expertise and enthusiasm for innovation to Xcellerant Ventures.
M.D. FARVO
Dr. Barbara Wirostko, a serial entrepreneur, is the Chief Medical Officer and Co-Founder of Qlaris Bio. Dr. Wirostko is a board-certified practicing glaucoma specialist holding a Clinical Adjunct Professor position at the University of Utah, in Ophthalmology at Moran Eye Center and in the Dept. of Biomedical Engineering. She was previously the Chief Medical Officer of EyeGate Pharmaceuticals following its acquisition of Jade Therapeutics where Dr. Wirostko was Co-Founder and Chief Scientific Officer spearheading the strategy and operations for the preclinical and clinical development of the unique hyaluronic acid, Ocular Bandage Gel (OBG), for human use. For Jade Therapeutics, Dr Wirostko received upwards of 3 M in SBIR funding as the Principle Investigator for the OBG polymer from the Dept of Defense and National Science Foundation. Prior to Jade, she served as the Chief Medical Officer of Altheos, a glaucoma startup company, and held leadership positions in medical and clinical development at Pfizer in Ophthalmology, overseeing the global medical responsibilities for the Xalatan franchise as Senior Medical Director. She sits on various editorial boards including the prestigious Ophthalmology Glaucoma and Journal of Glaucoma, has published and written hundreds of peer reviewed papers, books, serves on numerous advisory boards, grant review committees, and holds fellowship positions with The Association for Research in Vision and Ophthalmology and the American Academy of Ophthalmology.
She has been invited globally to lecture on her area of clinical research expertise, exfoliation glaucoma. Dr. Wirostko received her MD from and completed her residency at Columbia University, College of Physicians and Surgeons, NY, and holds a BA with distinction in Microbiology from Cornell University.
Following the death of their oldest son, Dr. Wirostko with her husband Dr. Joseph Morelli founded a nonprofit for young students with learning challenges. Started in 2014, under Dr. Wirostko’s directorship, the Joseph James Morelli Legacy Foundation is now a nationally recognized 501c3, having awarded 100s of students’ scholarships around the country, to help recognize and advocate for dyslexia. Her outreach and advocacy have included a TedX talk in April 2019 on the story of Joseph. Dr. Wirostko currently lives in Park City, Utah with her husband and children, enjoying skiing and the outdoors.
